A similar differential modulation of the BAX and Bcl-XL ratio by two-drug combinations was demonstrated in studies using human colon tumor cells (McMasters et al., 2000) in the past, which was implicated in the development of cancer and related to the mechanism of cell death induced by pro-apoptotic agents. The gene discussed is BCL2L1; the disease is colonic neoplasm.